Sputnik Single-Dose Vaccine Trial Gets Approval From DGCI
The third Phase trial of the Sputnik light, a single-dose vaccine in India has been granted permission by the Drugs Controller General of India (DCGI). A study published in The Lancet showed Sputnik light has 78.6 to 83.7% efficacy against Covid. It is higher than two shot vaccines. The CDSCO committee stated that Sputnik light is the same as Sputnik V. Its safety or immunogenicity has been previously tested.